Ovarian cancer immunotherapy: opportunities, progresses and challenges
/in International Publications, Ovarian CancerPotent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
/in Dendritic Cells, International PublicationsThe anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting
/in International Publications, Newcastle Disease VirusMulticenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology
/in International Publications, MicronutrientsGeneration of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28
/in Dendritic Cells, International PublicationsWhat’s the place of immunotherapy in malignant mesothelioma treatments?
/in Dendritic Cells, International Publications, Malignant Pleural MesotheliomaPresentation of tumour antigens by dendritic cells and challenges faced
/in Dendritic Cells, International PublicationsRac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
/in International Publications, Newcastle Disease VirusTocotrienols are good adjuvants for developing cancer vaccines
/in Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer